Bayesian Capital Management, LP Vir Biotechnology, Inc. Transaction History

Bayesian Capital Management, LP

  • $838 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$8.6 - $11.9 $220,160 - $304,640
25,600 New
25,600 $259,000
Q1 2022

May 16, 2022
SELL
$21.19 - $40.01 $117,392 - $221,655
-5,540 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$30.97 - $54.03 $171,573 - $299,326
5,540 New
5,540 $232,000

Others Institutions Holding VIR

# of Institutions
218
Shares Held
87.1M
Call Options Held
165K
Put Options Held
1.23M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.21B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email